U-Neuron Biomedical Inc

ROCO:6973 (Taiwan)  
NT$ 46.90 (0%) Jun 7
At Loss
P/B:
2.82
Market Cap:
NT$ 1.39B ($ 42.72M)
Enterprise V:
NT$ 919.60M ($ 28.34M)
Volume:
4.00
Avg Vol (2M):
30.96K
Volume:
4.00
At Loss
Avg Vol (2M):
30.96K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for U-Neuron Biomedical Inc ( ) from 2023 to Jun 10 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. U-Neuron Biomedical stock (ROCO:6973) PE ratio as of Jun 10 2024 is 0. More Details

U-Neuron Biomedical Inc (ROCO:6973) PE Ratio (TTM) Chart

To

U-Neuron Biomedical Inc (ROCO:6973) PE Ratio (TTM) Historical Data

Total 106
  • 1
  • 2
U-Neuron Biomedical PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-10 At Loss 2024-04-03 At Loss
2024-06-07 At Loss 2024-04-02 At Loss
2024-06-06 At Loss 2024-04-01 At Loss
2024-06-05 At Loss 2024-03-29 At Loss
2024-06-04 At Loss 2024-03-28 At Loss
2024-06-03 At Loss 2024-03-27 At Loss
2024-05-31 At Loss 2024-03-26 At Loss
2024-05-30 At Loss 2024-03-25 At Loss
2024-05-29 At Loss 2024-03-22 At Loss
2024-05-28 At Loss 2024-03-21 At Loss
2024-05-27 At Loss 2024-03-20 At Loss
2024-05-24 At Loss 2024-03-19 At Loss
2024-05-23 At Loss 2024-03-18 At Loss
2024-05-22 At Loss 2024-03-15 At Loss
2024-05-21 At Loss 2024-03-14 At Loss
2024-05-20 At Loss 2024-03-13 At Loss
2024-05-17 At Loss 2024-03-12 At Loss
2024-05-16 At Loss 2024-03-11 At Loss
2024-05-15 At Loss 2024-03-08 At Loss
2024-05-14 At Loss 2024-03-07 At Loss
2024-05-13 At Loss 2024-03-06 At Loss
2024-05-10 At Loss 2024-03-05 At Loss
2024-05-09 At Loss 2024-03-04 At Loss
2024-05-08 At Loss 2024-03-01 At Loss
2024-05-07 At Loss 2024-02-29 At Loss
2024-05-06 At Loss 2024-02-27 At Loss
2024-05-03 At Loss 2024-02-26 At Loss
2024-05-02 At Loss 2024-02-23 At Loss
2024-04-30 At Loss 2024-02-22 At Loss
2024-04-29 At Loss 2024-02-21 At Loss
2024-04-26 At Loss 2024-02-20 At Loss
2024-04-25 At Loss 2024-02-19 At Loss
2024-04-24 At Loss 2024-02-16 At Loss
2024-04-23 At Loss 2024-02-15 At Loss
2024-04-22 At Loss 2024-02-05 At Loss
2024-04-19 At Loss 2024-02-02 At Loss
2024-04-18 At Loss 2024-02-01 At Loss
2024-04-17 At Loss 2024-01-31 At Loss
2024-04-16 At Loss 2024-01-30 At Loss
2024-04-15 At Loss 2024-01-29 At Loss
2024-04-12 At Loss 2024-01-26 At Loss
2024-04-11 At Loss 2024-01-25 At Loss
2024-04-10 At Loss 2024-01-24 At Loss
2024-04-09 At Loss 2024-01-23 At Loss
2024-04-08 At Loss 2024-01-22 At Loss

U-Neuron Biomedical Inc (ROCO:6973) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Compare
Compare
Traded in other countries / regions
6973.Taiwan
IPO Date
2023-07-20
Description
U-Neuron Biomedical Inc is engaged in research and development of stem cell storage & separation technology, and treatment application technology. It has patent on the Technology of Culture and Isolation of Amniotic Fluid Stem Cell.